This content is machine translated Small cell lung carcinoma Durvalumab approved as first immunotherapy for patients with LS-SCLC Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, limited-stage small cell lung cancer) whose disease has...…
View Post 5 min This content is machine translated European Lung Cancer Conference in Geneva Therapy of small cell lung tumors – focus on neutropenia Update on the use of granulocyte colony stimulating factor (G-CSF) in concurrent chemoradiotherapy. Administration in patients with small cell lung cancer may be safer than previously thought.
